“The efficacy and safety of Atogepant for migraine prophylaxis: a systematic review and meta-analysis of randomized controlled trials”
Abstract Background Migraine is a complex neurological disorder characterized by recurrent, disabling headaches and various sensory symptoms, affecting about 15% of the global population annually. It is the second most common neurological condition worldwide, causing significant disability. While cu...
Saved in:
| Main Authors: | Ayesha Shaukat, Laiba Shakeel, Rumaisa Riaz, Saad Ashraf, Aymar Akilimali |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-08-01
|
| Series: | BMC Neurology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12883-025-04350-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacokinetics of Atogepant in Healthy Lactating Female Participants: Results from a Phase 1 Lactation Study
by: Ramesh R. Boinpally, et al.
Published: (2025-06-01) -
One-month atogepant treatment induces rapid changes in delta-band functional connectivity in migraine: an HD-EEG study
by: Matteo Conti, et al.
Published: (2025-07-01) -
Disrupting Migraine Dynamics: A Narrative Review of the Consequences of Modern Anti-CGRP Monoclonal Antibody Therapies
by: Dawn C. Buse, et al.
Published: (2025-05-01) -
A review of migraine treatment methods: a comparative analysis of therapeutic approaches
by: Paweł Nojek, et al.
Published: (2024-11-01) -
Comprehensive preventive treatments for episodic migraine: a systematic review of randomized clinical trials
by: María-Karina Vélez-Jiménez, et al.
Published: (2025-08-01)